FIELD: biochemistry; medicine.
SUBSTANCE: invention relates to biochemistry and medicine and represents a pharmaceutical composition for treating neurodegenerative diseases, containing an effective amount of HAEE peptide in an equimolar complex HAEE-Zn-HSA with zinc and human serum albumin in the form of a solution for intravenous administration with a pharmaceutically acceptable carrier selected from a circle of neutral carriers and diluents.
EFFECT: technical result consists in improvement of stability and bioavailability of active substance – peptide HAEE, as well as in improvement of cognitive functions.
1 cl, 5 dwg, 6 tbl, 4 ex
